SB-742457

For research use only. Not for therapeutic Use.

  • CAT Number: I004290
  • CAS Number: 607742-69-8
  • Molecular Formula: C₁₉H₁₉N₃O₂S
  • Molecular Weight: 353.44
  • Purity: ≥95%
Inquiry Now

SB-742457(Cat No.:I004290)is a selective antagonist of the metabotropic glutamate receptor 5 (mGluR5), a G-protein-coupled receptor involved in regulating synaptic plasticity and neurotransmission. By inhibiting mGluR5, SB-742457 has shown potential in modulating glutamatergic signaling, which plays a critical role in conditions like anxiety, depression, and cognitive disorders. It has been investigated for its therapeutic effects in treating psychiatric and neurological diseases, including Fragile X syndrome and other neurodevelopmental disorders. SB-742457 may help alleviate symptoms by restoring balance in glutamate signaling, offering a potential treatment for disorders with dysregulated mGluR5 activity.


Catalog Number I004290
CAS Number 607742-69-8
Synonyms

3-(benzenesulfonyl)-8-piperazin-1-ylquinoline

Molecular Formula C₁₉H₁₉N₃O₂S
Purity ≥95%
Target Neuronal Signaling
Solubility 10 mM in DMSO
Storage 3 years -20C powder
IC50 9.63 (pKi)
IUPAC Name 3-(benzenesulfonyl)-8-piperazin-1-ylquinoline
InChI InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2
InChIKey JJZFWROHYSMCMU-UHFFFAOYSA-N
SMILES C1CN(CCN1)C2=CC=CC3=CC(=CN=C32)S(=O)(=O)C4=CC=CC=C4
Reference

</br>1:The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour. Higgs S, Cooper AJ, Barnes NM.Psychopharmacology (Berl). 2016 Feb;233(3):417-24. doi: 10.1007/s00213-015-4112-x. Epub 2015 Oct 28. PMID: 26507195 Free PMC Article</br>2:SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. Maher-Edwards G, Dixon R, Hunter J, Gold M, Hopton G, Jacobs G, Hunter J, Williams P.Int J Geriatr Psychiatry. 2011 May;26(5):536-44. doi: 10.1002/gps.2562. Epub 2010 Sep 24. PMID: 20872778 </br>3:Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer/’s disease. Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, Davy M, Williams P.Curr Alzheimer Res. 2010 Aug;7(5):374-85. PMID: 20043816

Request a Quote